Akeso, Inc. (9926) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sino Biopharmaceutical Ltd.

WuXi AppTec Co., Ltd.

China Medical System Holdings Ltd.

Sinopharm Group Co., Ltd.

China Resources Pharmaceutical Group Ltd.

Hygeia Healthcare Holdings Co., Ltd.

Hansoh Pharmaceutical Group Co., Ltd.

Innovent Biologics, Inc.

HUTCHMED (China) Ltd.

Akeso, Inc.

BeiGene Ltd.

Why is Akeso, Inc. ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 8.59%

Poor long term growth as Operating profit has grown by an annual rate -15.87% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -53.96

Negative results in Dec 24

INVENTORY TURNOVER RATIO(HY) Lowest at 0.69%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 96.84%, its profits have fallen by -124.5%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Akeso, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Akeso, Inc.

88.92%

3.01

68.64%

Hang Seng Hong Kong

27.36%

1.03

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

102.83%

EBIT Growth (5y)

-15.87%

EBIT to Interest (avg)

-53.96

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.50

Sales to Capital Employed (avg)

0.24

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

15.27%

ROE (avg)

8.59%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

19.27

EV to EBIT

-219.14

EV to EBITDA

-331.30

EV to Capital Employed

37.39

EV to Sales

59.12

PEG Ratio

Dividend Yield

ROCE (Latest)

-17.06%

ROE (Latest)

-7.49%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Akeso, Inc.

Net Profit

Higher at HKD -290.49 MM

than preceding 12 month period ended Dec 2024

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Operating Cash Flow

Highest at HKD 1,918.65 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Net Sales

At HKD 1,192.43 MM has Grown at 29.73%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Pre-Tax Profit

At HKD -225.33 MM has Grown at 59.99%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Cash and Eqv

Highest at HKD 7,815.41 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by 1.16% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at HKD 114.05 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 114.05 MM has Grown at 18.48%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Akeso, Inc.

Inventory Turnover Ratio

Lowest at 0.69%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio